Nu Skin Enterprises, Inc.
NUS
$6.55
-$0.08-1.21%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.04% | -16.89% | -15.33% | -12.06% | -12.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.04% | -16.89% | -15.33% | -12.06% | -12.66% |
| Cost of Revenue | -9.69% | -15.10% | -16.47% | -8.72% | -4.64% |
| Gross Profit | -13.16% | -17.60% | -14.84% | -13.49% | -16.02% |
| SG&A Expenses | -9.99% | -16.63% | -17.00% | -17.09% | -16.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.89% | -16.16% | -16.83% | -14.43% | -12.97% |
| Operating Income | -61.44% | -26.43% | 18.71% | 29.37% | -4.67% |
| Income Before Tax | -98.07% | 131.47% | 20.27% | 120.82% | 12,125.34% |
| Income Tax Expenses | -97.18% | 117.05% | -121.72% | 146.99% | 1,557.65% |
| Earnings from Continuing Operations | -98.29% | 140.14% | 105.72% | 117.86% | 20,271.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.29% | 140.14% | 105.72% | 117.86% | 20,271.67% |
| EBIT | -61.44% | -26.43% | 18.71% | 29.37% | -4.67% |
| EBITDA | -38.11% | -24.74% | -5.12% | 5.88% | -14.47% |
| EPS Basic | -98.24% | 141.07% | 107.01% | 117.95% | 20,104.63% |
| Normalized Basic EPS | -60.64% | -137.64% | 233.49% | 214.95% | 40.62% |
| EPS Diluted | -98.22% | 138.61% | 103.59% | 117.95% | 19,914.81% |
| Normalized Diluted EPS | -61.15% | -136.64% | 227.65% | 214.59% | 38.98% |
| Average Basic Shares Outstanding | -3.14% | -2.28% | -0.62% | -0.50% | 0.46% |
| Average Diluted Shares Outstanding | -1.80% | 0.40% | 1.16% | -0.38% | 1.59% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 55.04% | 3.43% | -0.52% | 6.57% | 1.01% |